Sandoz Nadolol 40mg Tablets Recall: Failed Dissolution Test
Sandoz recalls 40mg Nadolol tablets due to failed dissolution test. This means the medication may not work as intended. Consumers should contact the manufacturer for details.
Lower-risk recall
Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)
Contact the company
What happened, in plain English
Sandoz is recalling 40mg Nadolol tablets that failed a dissolution test. This could mean the medication doesn't work properly. Affected consumers should contact Sandoz for instructions. Read more at govinfonow.com/recall/42108-sandoz-nadolol-40mg-tablets-recall-failed-dissolution-test.
Source Summary by GovInfoNow · govinfonow.com/recall/42108-sandoz-nadolol-40mg-tablets-recall-failed-dissolution-test · Updated October 8, 2026 · FDA enforcement record: FDA #D-0236-2017
Cite this page
“Sandoz Nadolol 40mg Tablets Recall: Failed Dissolution Test.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42108-sandoz-nadolol-40mg-tablets-recall-failed-dissolution-test. Based on FDA recall #D-0236-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0236-2017%22&limit=1).
Why it’s dangerous
The tablets failed a dissolution test, meaning they may not dissolve properly in the body. This could lead to the medication not working as intended. The issue is specific to the manufacturing batch and not the product itself.
Who’s affected
People with a prescription for 40mg Nadolol tablets who bought them from Sandoz. Those with heart conditions are most at risk.
How to tell if you have this one
Check for the NDC code 0781-1182-10 and lot number GG1539 on the packaging. The product is a 1000-count bottle of 40mg tablets sold by prescription.
- Brand
Sandoz- Category
Drug
What to do — step by step
Contact Sandoz
Reach out to Sandoz Incorporated for specific instructions on what to do with the recalled product.
Where it went and when
Where it was distributed
Distributed in Mississippi and Ohio.
FDA distribution: “MS and OH.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Mississippi, Ohio.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0236-2017 (December 22, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0236-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.